Publication reference：

Google Scholar: https://scholar.google.com/citations?user=hRE4IbMAAAAJ&hl=zh-TW

ORCID：https://orcid.org/0000-0001-9691-7507

2025 期刊論文

1. Saptarshi Bhattacharyya, Ming-Lung Yu, Phumelele Yvonne Siphepho, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Shu-Chi Wang*. Retrospective Analysis of Steatosis Effect on Antiviral Response and Hepatocellular Carcinoma Risk in Chronic Hepatitis C. Antiviral Research. In press. (JCR=2023, IF=4.5, PHARMACOLOGY & PHARMACY Ranking: 60/354=16.8%) 本人為通訊作者.
2. Yen-Yu Chen, Chi-Sheng Chen, Jee-Fu Huang, Wen-Hsiu Su, Chia-Yang Li, Wei-Shiun Chen, En-Sheng Lin, Wan-Long Chuang, Ming-Lung Yu, Shu-Chi Wang*. The obesity-related mutation gene on nonalcoholic fatty liver disease. Human Genetics. 2025 Jan;144(1):1-14. (JCR=2023, IF=3.8, MEDICINE, GENETICS & HEREDITY Ranking: 49/191=25.7%) 本人為通訊作者.
3. Meng-Hsuan Cheng, Hsiao-Hsuan Wang, Mo Da-Sang Hua, Hsuan-Fu Kuo, Zi-Jing Lin, Chong-Chao Hsieh, Chih-Hsin Hsu, Chia-Yang Li, Shu-Chi Wang, Yung-Hsiang Chen, Szu-Hui Wu, Wei-Lun Liu, Po-Len Liu. Magnolol facilitates mitochondrial-peroxisome dysfunction and induces oxeiptosis in lung cancer cells following transfer via tunneling nanotubes. Biomedicine & Pharmacotherapy. 2025 Jun:187:118126. (JCR=2023, IF=6.9, PHARMACOLOGY & PHARMACY. Ranking: 15/354=4.1%)
4. Szu-Jen Wang, Chung-Feng Huang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chien-Wei Huang, Lee-Won Chong, Pin-Nan Cheng, Ming-Lun Yeh, Cheng-Yuan Peng, Chien-Yu Cheng, Jee-Fu Huang, Ming-Jong Bair, Chih-Lang Lin, Chi-Chieh Yang, Hsing-Tao Kuo, Tsai-Yuan Hsieh, Tzong-Hsi Lee, Pei-Lun Lee, Wen-Chih Wu, Chih-Lin Lin, Wei-Wen Su, Sheng-Shun Yang, Chia-Chi Wang, Jui-Ting Hu, Lein-Ray Mo, Chun-Ting Chen, Yi-Hsiang Huang, Chun-Chao Chang, Chia-Sheng Huang, Guei-Ying Chen, Chien-Neng Kao, Chi-Ming Tai, Chun-Jen Liu, Mei-Hsuan Lee, Pei-Chien Tsai, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wang-Long Chuang, Kuo-Chih Tseng, Chi-Yi Chen, Shu-Chi Wang, Ming-Lung Yu. Real-world efficacy and safety of universal 8-week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre-end-stage renal disease: Insights from a nationwide hepatitis C virus registry in Taiwan. Kaohsiung Journal Of Medical Sciences. 2025 Feb;41(2):e12929. (JCR=2023, IF=2.7, MEDICINE, RESEARCH & EXPERIMENTAL Ranking: 95/189=50.2%)

2024 期刊論文

5. Ciniso Sylvester Shabangu, Wen-Hsiu Su, Chia-Yang Li, Ming-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Shu-Chi Wang*. Systematic Integration of Molecular and Clinical Approaches in HCV-Induced Hepatocellular Carcinoma. Journal of Translational Medicine. 2024 Mar 12;22(1):268. (JCR=2023, IF=6.1, MEDICINE, RESEARCH & EXPERIMENTAL Ranking: 29/189=15.1%) 本人為通訊作者.
6. Pin-Rong Chen, Chia-Yang Li, Taha Yazal, I-Chen Chen, Po-Len Liu, Yi-Ting Chen, Ching-Chih Liu , Jung Lo, Tzu-Chieh Lin, Ching-Tang Chang, Hsin-En Wu, Yuan-Ru Chen, Wei-Chung Cheng, Chien-Chih Chiu, Chi-Shuo Chen, Shu-Chi Wang*. Protective effects of nordalbergin against LPS-induced endotoxemia through inhibiting MAPK/NF-κB signaling pathway, NLRP3 inflammasome activation, and ROS production. Inflammation Research. 2024 Oct;73(10):1657-1670. (JCR=2023, IF=4.8, IMMUNOLOGY Ranking: 52/181=28.7%) 本人為通訊作者.
7. Ting-En Chen, Jung Lo, Shu-Pin Huang, Kun-Che Chang, Po-Len Liu, Hsin-En Wu, Yuan-Ru Chen, Yo-Chen Chang, Ching-Chih Liu, Po-Yen Lee, Yu-Hung Lai, Pei-Chang Wu, Shu-Chi Wang*, Chia-Yang Li*. Glaucine inhibits hypoxia-induced angiogenesis and attenuates LPS-induced inflammation in human retinal pigment epithelial ARPE-19 cells. European Journal of Pharmacology. 2024 Oct 15;981:176883. (JCR=2023, IF=4.2, PHARMACOLOGY & PHARMACY Ranking: 75/354=21.2%) 本人為通訊作者
8. Chia-Hsin Liu, Yo-Liang Lai, Pei-Chun Shen, Hsiu-Cheng Liu, Meng-Hsin Tsai, Yu-De Wang, Wen-Jen Lin, Fang-Hsin Chen, Chia-Yang Li, Shu-Chi Wang, Mien-Chie Hung, Wei-Chung Cheng. DriverDBv4: a multi-omics integration database for cancer driver gene research. Nucleic Acids Research. 2024 Jan 5;52(D1):D1246-D1252. (JCR=2023, IF=6.1, BIOCHEMISTRY & MOLECULAR BIOLOGY Ranking: 6/313=1.9%) 跨校合作
9. Meng-Hsuan Cheng, Hsuan-Fu Kuo, Chia-Yuan Chang, Jui-Chi Chang, I-Fan Liu, Chong-Chao Hsieh , Chih-Hsin Hsu, Chia-Yang Li, Shu-Chi Wang, Yung-Hsiang Chen, Chuang-Rung Chang, Tsung-Ying Lee, Yu-Ru Liu, Chi-Yuan Huang, Szu-Hui Wu, Wei-Lun Liu, Po-Len Liu. Curcumin regulates pulmonary extracellular matrix remodeling and mitochondrial function to attenuate pulmonary fibrosis by regulating the miR-29a-3p/DNMT3A axis. Biomedicine & Pharmacotherapy. 2024 May;174:116572. (JCR=2023, IF=6.9, PHARMACOLOGY & PHARMACY Ranking: 15/354=4.2%)
10. Yu-Kai Huang, Tzu-Ming Wang, Chi-Yu Chen, Chia-Yang Li, Shu-Chi Wang, Khushboo Irshad, Yuan Pan, Kun-Che Chang. The role of ALDH1A1 in glioblastoma proliferation and invasion. Chemico-Biological Interactions. 2024 Oct 1;402:111202. (JCR=2023, IF=4.7, BIOCHEMISTRY & MOLECULAR BIOLOGY Ranking: 70/313=22.3%) 國際合作

2023期刊論文

11. Hsin-Tung Chien, Chia-Yang Li, Wen-Hsiu Su, Kun-Che Chang, Chi-Sheng Chen, Yi-Ting Liu, Chih-Yi Chen, Chia-Yen Dai, Shu-Chi Wang*. Multi-omics profiling of chemotactic characteristics of brain microglia and astrocytoma. Life Sciences. 2023 Oct 1:330:121855. (JCR=2022, IF=6.1, PHARMACOLOGY & PHARMACY Ranking: 34/278=12.1%) 本人為通訊作者
12. Taha Yazal , Po-Yen Lee, Pin-Rong Chen, I-Chen Chen, Po-Len Liu, Yuan-Ru Chen, Tzu-Chieh Lin, Yi-Ting Chen, Shu-Pin Huang, Hsin-Chih Yeh, Ching-Chih Liu, Jung Lo, Hsin-En Wu, Shu-Chi Wang*, Chia-Yang Li*. Kurarinone exerts anti-inflammatory effect via reducing ROS production, suppressing NLRP3 inflammasome, and protecting against LPS-induced sepsis. Biomedicine & Pharmacotherapy. 2023 Nov:167:115619. (JCR=2022, IF=7.5, PHARMACOLOGY & PHARMACY Ranking: 22/278=7.7%)本人為通訊作者
13. Hsin-En Wu, Chia-Cheng Su, Shu-Chi Wang, Po-Len Liu, Wei-Chung Cheng, Hsin-Chih Yeh, Chih-Pin Chuu, Jen-Kun Chen, Bo-Ying Bao, Cheng Hsueh Lee, Chien-Chih Ke, Yuan-Ru Chen, Yun-Hsin Yu, Shu-Pin Huang*, Chia-Yang Li*. Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway. AMERICAN JOURNAL OF CHINESE MEDICINE. 2023;51(4):1019-1039. 2023 Jul. (JCR=2022, IF=5.7, INTEGRATIVE & COMPLEMENTARY MEDICINE Ranking: 3/28=9.9%)
14. I-Fan Liu, Tzu-Chieh Lin, Shu-Chi Wang, Chia-Hung Yen, Chia-Yang Li, Hsuan-Fu Kuo, Chong-Chao Hsieh, Chia-Yuan Chang, Chuang-Rung Chang, Yung-Hsiang Chen, Yu-Ru Liu, Tsung-Ying Lee, Chi-Yuan Huang, Chih-Hsin Hsu, Shing-Jong Lin, Po-Len Liu. Long-term administration of Western diet induced metabolic syndrome in mice and causes cardiac microvascular dysfunction, cardiomyocyte mitochondrial damage, and cardiac remodeling involving caveolae and caveolin-1 expression. Biology Direct. 2023 Mar 6;18(1):9. (JCR=2022, IF=5.5, BIOLOGY Ranking: 13/92=13.6%)
15. Ming-Ying Lu, Ta-Wei Liu, Po-Cheng Liang, Ching-I Huang, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Wen-Hsuan Wang , Ching-Chih Lin, Kuan-Yu Chen, Shu-Chi Wang, Yu-Ju Wei, Po-Yao Hsu, Tyng-Yuan Jang, Ming-Yen Hsieh, Chih-Wen Wang, Ming-Lun Yeh, Zu-Yau Lin, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu. Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradication. American Journal of Cancer Research. 2023 Jan 15;13(1):190-203. (JCR=2022, IF=5.3, ONCOLOGY Ranking: 70/241=28.8%)
16. Yu-Hung Lai, Wei-Lun Liu, Tsung-Ying Lee, Chung-Wen Kuo, Yu-Ru Liu, Chi-Yuan Huang, Yung-Hsiang Chen, I-Ling Chen, Szu-Hui Wu, Shu-Chi Wang, Po-Yen Lee, Ching-Chih Liu, Jung Lo, Yo-Chen Chang, Hsuan-Fu Kuo, Chong-Chao Hsieh, Chia-Yang Li, Po-Len Liu. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo. 2023 Feb:110:154597. (JCR=2022, IF=7.9, INTEGRATIVE & COMPLEMENTARY MEDICINE Ranking: 1/28=1.8%)

2022期刊論文

17. Yuan-Ru Chen#, Shu-Chi Wang#, Shu-Pin Huang, Chia-Cheng Su, Po-Len Liu, Wei-Chung Cheng, Chih-Pin Chuu, Jen-Kun Chen, Bo-Ying Bao, Cheng Hsueh Lee, Chien-Chih Ke, Hsin-En Wu, Hao-Han Chang, Hsin-Chih Yeh, Chia-Yang Li. Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways. Biomedicine & Pharmacotherapy. 2022, Dec 156:113929. (JCR=2021, IF=7.419, PHARMACOLOGY & PHARMACY Ranking=26/279(9.14%)) 本人為第一作者
18. Jung Lo, Ching-Chih Liu, Yueh-Shan Li, Po-Yen Lee, Po-Len Liu, Pei-Chang Wu, Tzu-Chieh Lin, Chi-Shuo Chen, Chien-Chih Chiu, Yu-Hung Lai, Yo-Chen Chang, Hsin-En Wu, Yuan-Ru Chen, Yu-Kai Huang, Shu-Pin Huang, Shu-Chi Wang*, Chia-Yang Li*. Punicalagin Attenuates LPS-Induced Inflammation and ROS Production in Microglia by Inhibiting the MAPK/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation. Journal of Inflammation Research., 2022, Sep 15;15:5347-5359. 本人為通訊作者.
19. Hsin-Chih Yeh, Chia-Cheng Su, Yen-Hsuan Wu, Cheng Hsueh Lee, Bo-Ying Bao, Wei-Chung Cheng, Shu-Chi Wang, Po-Len Liu, Chien-Chih Chiu, Chih-Pin Chuu, Chien-Chih Ke, Hsin-En Wu, Yuan-Ru Chen, Wei-Ju Chung, Shu-Pin Huang, Chia-Yang Li. (2022, May) Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer. European Journal of Pharmacology., 15;923:174929.
20. Yo-Liang Lai, Chia-Hsin Liu, Shu-Chi Wang, Shu-Pin Huang, Yi-Chun Cho, Bo-Ying Bao, Chia-Cheng Su, Hsin-Chih Yeh, Cheng-Hsueh Lee, Pai-Chi Teng, Chih-Pin Chuu, Deng-Neng Chen, Chia-Yang Li, Wei-Chung Cheng. (2022, Mar) Identification of a Steroid Hormone-Associated Gene Signature Predicting the Prognosis of Prostate Cancer through an Integrative Bioinformatics Analysis. Cancers., 19;14(6):1565.
21. Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, Shu-Chi Wang, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu. (2022, Jan) Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication. World Journal of Gastroenterology., 7;28(1):140-153.

2021期刊論文

22. Yvonne Siphepho, Yi-Ting Lu, Ciniso Sylvester Shabangu, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Ming-Lung Yu, Shu-Chi Wang*. (2021, Oct). The Impact of Steatosis on Chronic Hepatitis C Progression & Response to Antiviral Treatments. Biomedicines., 17;9(10):1491. 本人為通訊作者.
23. Ciniso Sylvester Shabangu, Phumelele Yvonne Siphepho, Chia-Yang Li, Wei-Chung Cheng, Ming-Ying Lu, Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Zu-Yau Lin, Ming-Lung Yu, Shu-Chi Wang*. (2021, Sep).The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 Expression. , 11;9(10):1446. MOST 108-2314-B-037-079-MY3.本人為通訊作者.
24. Keva Joseph, Ciniso Sylvester Shabangu, Tyng-Yuan Jang, Chung-Feng Huang, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu, Shu-Chi Wang*. (2021, Sep). The Prevalence and Serological Association of Hepatitis D Virus Genotypes in Taiwan. Pathogens, 10, 1227. MOST 108-2314-B-037-079-MY3. 本人為通訊作者.
25. Po-Yen Lee, Yu-Hung Lai, Po-Len Liu, Ching-Chih Liu, Chia-Cheng Su, Fang-Yen Chiu, Wei-Chung Cheng, Shiuh-Liang Hsu, Kai-Chun Cheng, Li-Yi Chiu, Tzu-En Kao, Chia-Ching Lin, Yo-Chen Chang, Shu-Chi Wang*, Chia-Yang Li. (2021, Sep). Toxicity of amantadine hydrochloride on cultured bovine cornea endothelial cells. Scientific reports. 16;11(1):18514.. 本人為通訊作者.
26. Shu-Chi Wang#, Chia-Yang Li, Wen-Tsan Chang, Wei-Chung Cheng , Chia-Hung Yen, Wen-Yu Tu, Zu-Yau Lin, Ching-Chih Lin, Ming-Lun Yeh, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Yao-Li Chen, Ming-Lung Yu. (2021, May). Exosome-derived differentiation antagonizing non-protein coding RNA with risk of HCV-related hepatocellular carcinoma recurrence. Liver International, 41(5):956-968. MOST 108-2314-B-037-079-MY3. 本人為第一作者.
27. I-Chen Chen, Shu-Chi Wang, Yi-Ting Chen, Hsin-Han Tseng, Po-Len Liu, Tzu-Chieh Lin, Hsin-En Wu, Yuan-Ru Chen, Yu-Hsin Tseng, Jong-Hau Hsu, Zen-Kong Dai, Jau-Ling Suen, Chia-Yang Li. (2021, Oct). Corylin Ameliorates LPS-Induced Acute Lung Injury via Suppressing the MAPKs and IL-6/STAT3 Signaling Pathways. Pharmaceuticals (Basel). 14;14(10):1046.
28. Po-Yen Lee, Ching-Chih Liu, Shu-Chi Wang, Kai-Yin Chen, Tzu-Chieh Lin, Po-Len Liu, Chien-Chih Chiu, I-Chen Chen, Yu-Hung Lai, Wei-Chung Cheng, Wei-Ju Chung, Hsin-Chih Yeh, Chi-Han Huang, Chia-Cheng Su, Shu-Pin Huang, Chia-Yang Li. (2021, Aug). Mycotoxin Zearalenone Attenuates Innate Immune Responses and Suppresses NLRP3 Inflammasome Activation in LPS-Activated Macrophages. Toxins, 25;13(9):593.
29. Ming-Lun Yeh, Po-Cheng Liang, Pei-Chien Tsai, Shu-Chi Wang, Jennifer Leong, Eiichi Ogawa, Dae Won Jun, Cheng-Hao Tseng, Charles Landis, Yasuhito Tanaka, Chung-Feng Huang, Jun Hayashi, Yao-Chun Hsu, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Mindie H Nguyen, Ming-Lung Yu. (2021, Jul). Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR. Cancers (Basel). 2021 Jul 9;13(14):3455.
30. Tsung-Ying Yang, Hao-Yun Kao, Po-Liang Lu, Pei-Yu Chen, Shu-Chi Wang, Liang-Chun Wang, Ya-Ju Hsieh, Sung-Pin Tseng. (2021, Aug). Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant Klebsiella pneumoniae. Pharmaceuticals., 12;14(8):795..
31. Jeffrey Yung-Chuan Chao, Hsin-Chuan Chang, Jeng-Kai Jiang, Chih-Yung Yang, Fang-Hsin Chen, Yo-Liang Lai, Wen-Jen Lin, Chia-Yang Li, Shu-Chi Wang, Muh-Hwa Yang, Yu-Feng Lin, Wei-Chung Cheng. (2021, Jul). Using bioinformatics approaches to investigate driver genes and identify BCL7A as a prognostic gene in colorectal cancer. Computational and structural biotechnology journal., 1;19:3922-3929.
32. Chi-Han Huang, Shu-Chi Wang, I-Chen Chen, Yi-Ting Chen, Po-Len Liu, Shih-Hua Fang, Shu-Pin Huang, Hsin-Chih Yeh, Ching-Chih Liu, Po-Yen Lee, Tzu-Chieh Lin, Wei-Chung Cheng, Chia-Cheng Su, Hsin-En Wu, Yuan-Ru Chen, Chia-Yang Li. (2021, Jun). Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation. Pharmaceuticals., 18;14(6):588..
33. Chia-Cheng Su, Shu-Chi Wang, I-Chen Chen, Fang-Yen Chiu, Po-Len Liu, Chi-Han Huang, Kuan-Hua Huang, Shih-Hua Fang, Wei-Chung Cheng, Shu-Pin Huang, Hsin-Chih Yeh, Ching-Chih Liu, Po-Yen Lee, Ming-Yii Huang, Chia-Yang Li. (2021, May). Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages. Frontiers in pharmacology., 11;12:652860..
34. Shu-Hsuan Liu, Kai-Wen Hsu, Yo-Liang Lai, Yu-Feng Lin, Fang-Hsin Chen, Pei-Hwa Peng, Li-Jie Lin, Heng-Hsiung Wu, Chia-Yang Li, Shu-Chi Wang, Min-Zu Wu, Yuh-Pyng Sher, Wei-Chung Cheng, (2021, May). Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma. Molecular therapy. Nucleic acids., 1;25:1-10..
35. Lu MY, Chen CT, Shih YL, Tsai PC, Hsieh MH, Huang CF, Yeh ML, Huang CI, Wang SC, Tsai YS, Ko YM, Lin CC, Chen KY, Wei YJ, Hsu PY, Hsu CT, Jang TY, Liu TW, Liang PC, Hsieh MY, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Yu ML, Chang WY. (2021, Apr). Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan. Scientific reports, 20;11(1):8554..
36. Tyng-Yuan Jang, Yu-Ju Wei, Ming-Lun Yeh, Shu-Fen Liu, Cheng-Ting Hsu, Po-Yao Hsu, Ta-Wei Liu, Yi-Hung Lin, Po-Cheng Liang, Meng-Hsuan Hsieh, Yu-Min Ko, Yi-Shan Tsai, Kuan-Yu Chen, Ching-Chih Lin, Pei-Chien Tsai, Shu-Chi Wang, Ching-I Huang, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang, Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, Ming-Lung Yu. (2021, Apr). Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues. Journal of the Formosan Medical Association. 120(1 Pt 2):303-310.
37. Liu WL, Li CY, Cheng WC, Chang CY, Chen YH, Lu CY, Wang SC, Liu YR, Cheng MH, Chong IW, Liu PL. (2021, Mar). High Mobility Group Box 1 Promotes Lung Cancer Cell Migration and Motility via Regulation of Dynamin-Related Protein 1. International Journal of Molecular Sciences, 31;22(7):3628..
38. Ting-Yi Lin, Meng-Chun Tsai, Wei Tu, Hsin-Chih Yeh, Shu-Chi Wang, Shu-Pin Huang, Chia-Yang Li (2021, Feb). Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks. Frontiers in Immunology., 3;11:610492..
39. Yu-Hung Lai, Po-Yen Lee, Chi-Yu Lu, Yu-Ru Liu, Shu-Chi Wang, Ching-Chih Liu, Yo-Chen Chang, Yung-Hsiang Chen, Chia-Cheng Su, Chia-Yang Li, Po-Len Liu. (2021, Jan). Thrombospondin 1-induced exosomal proteins attenuate hypoxia-induced paraptosis in corneal epithelial cells and promote wound healing. FASEB J., 35(1):e21200.

2020期刊論文

40. Tyng-Yuan Jang, Yu-Ju Wei, Cheng-Ting Hsu, Po-Yao Hsu, Ta-Wei Liu, Yi-Hung Lin, Po-Cheng Liang, Meng-Hsuan Hsieh, Yu-Min Ko, Yi-Shan Tsai, Kuan-Yu Chen, Ching-Chih Lin, Pei-Chien Tsai, Shu-Chi Wang, Ching-I Huang, Ming-Lun Yeh, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang, Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, Ming-Lung Yu. (2020, Nov). Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapy. Journal of gastroenterology and hepatology., 35(11):1886-1892
41. Ciniso Sylvester Shabangu, Jee-Fu Huang, Hui-Hua Hsiao, Ming-Lung Yu, Wan-Long Chuang, Shu-Chi Wang* (2020, May). Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases. International Journal of Molecular Sciences, 21:1-3732. MOST 108-2314-B-037-079-MY3. 本人為通訊作者.
42. Shu-Hsuan Liu, Pei-Chun Shen, Chen-Yang Chen, An-Ni Hsu, Yi-Chun Cho, Yo-Liang Lai, Fang-Hsin Chen, Chia-Yang Li, Shu-Chi Wang, Ming Chen, I-Fang Chung, Wei-Chung Cheng. (2020, Jan). DriverDBv3: a multi-omics database for cancer driver gene research. Nucleic acids research. 8;48(D1):D863-D870.

2003-2019期刊論文

43. Yung-Li Hung., Shu-Chi Wang., Katsuhiko Suzukic., Shih-Hua Fang., Chi-Shuo Chen., Wei-Chun gCheng., Chia-Cheng Su., Hsin-Chih Yeh.,Hung-Pin Tu. Po-Len Li., Ming-Yii Huang., Chia-Yang Li. (2019, Jun). Bavachin attenuates LPS-induced inflammatory response and inhibits the activation of NLRP3 inflammasome in macrophages.. , 59:152785..
44. Chia-Chi Liu, Ching-Fang Yu, Shu-Chi Wang, Hsueh-Yin Li, Chiu-Min Lin, Hsia-Han Wang, Carmen Abate, Chi-Shiun Chiang (2019, May). Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor. BMC Cancer, 20;19(1):473-482.
45. Hsuan-Fu Kuo, Chong-Chao Hsieh, Shu-Chi Wang, Chia-Yuan Chang, Chih-Hsin Hung, Po-Lin Kuo, Yu-Ru Liu, Chia-Yang Li, Po-Len Liu. Simvastatin Attenuates Cardiac Fibrosis via Regulation of Cardiomyocyte-Derived Exosome Secretion. Journal of Clinical Medicine., 2019 Jun 4;8(6):794.
46. Chung-Feng Huang, Shu-Chi Wang, Ming-Lun Yeh, Ching-I Huang, Pei-Chien Tsai, Zu-Yau Lin, Shinn-Cherng Chen, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Angela Chen, Ming-Lung Yu. (2019, Jan). Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.  Journal of Gastroenterology and Hepatology., 34(1):249-255.
47. Yung-Li Hung, Shu-Chi Wang, Katsuhiko Suzuki, Shih-Hua Fang, Chi-Shuo Chen, Wei-Chung Cheng, Chia-Cheng Su, Hsin-Chih Yeh, Hung-Pin Tu, Po-Len Liu, Ming-Yii Huang, Chia-Yang Li. (2018, Dec). Bavachin attenuates LPS-induced inßammatory response and inhibits the activation of NLRP3 inßammasome in macrophages. Phytomedicine. 59:152785.
48. Ming-Yii Huang, Chia-En Tu, Shu-Chi Wang, Yung-Li Hung, Chia-Cheng Su, Shih-Hua Fang, Chi-Shuo Chen, Po-Len Liu, Wei-Chung Cheng, Yu-Wei Huang, Chia-Yang Li. (2018, Aug). Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia.. BMC Complementary and Alternative Medicine., 15;18(1):221.
49. Kuo-Hua Lin, Ming-Yii Huang, Wei-Chung Cheng, Shu-Chi Wang, Shih-Hua Fang, Hung-Pin Tu, Chia-Cheng Su, Yung-Li Hung, Po-Len Liu, Chi-Shuo Chen, Yu-Ting Wang, Chia-Yang Li. (2018, Feb). RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment. Scientific Reports., 8(1):2672..
50. Chia-Yen Dai, Yi-Shan Tsai, Wen-Wen Chou, Tawei Liu, Chung-Feng Huang, Shu-Chi Wang, Pei-Chien Tsai, Ming-Lun Yeh, Ming-Yen Hsieh, Ching-I Huang, Shang-Yin Vanson Liu, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu (2018, Jan). The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infection. Oncotarget., 10;9(13):11291-11302.
51. Wang S. C.#, Lai KR, Li CY, Chiang CS, Yu GY, Naoya Sakamoto, Tu WT, Hsieh MH, Huang JF, Chuang WL, Dai CY, Yu ML. The paradoxical effects of different hepatitis C viral loads on host DNA damage and repair abilities. PLoS ONE. 2017 Jan 4;12(1):e0164281. (SCI, IF:2.806; 15/64 23.4% in MULTIDISCIPLINARY SCIENCES) 本人為第一作者.
52. Huang CF, Huang CI, Yeh ML, Wang S. C., Chen KY, Ko YM, Lin CC, Tsai YS, Tsai PC, Lin ZY, Chen SC, Dai CY, Huang JF, Chuang WL, Yu ML. Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C. 2017 May 16;8(20):32618-32625. (SCI, IF:5.168; 44/217 20.28% in ONCOLOGY)
53. Wang S. C.#, Yang JF, Wang CL, Huang CF, Lin YY, Chen YY, Lo CT, Lee PY, Wu KT, Lin CI, Hsieh MH, Chuang HY, Ho CK, Yu ML, Dai CY. Distinct subpopulations of hepatitis C virus infectious cells with different levels of intracellular hepatitis C virus core protein. Kaohsiung J Med Sci. 2016 Oct;32(10):487-493. (SCI, IF:1.150; 103/128 80.5% in MEDICINE, RESEARCH & EXPERIMENTAL) 本人為第一作者.
54. Hung YL, Fang SH, Wang S. C., Cheng WC, Liu PL, Su CC, Chen CS, Huang MY, Hua KF, Shen KH, Wang YT, Katsuhiko Suzuki, and Li CY. Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response. Sci Rep. 2017 Apr 11;7:46299. (SCI, IF:4.259; 10/64 15.6% in MULTIDISCIPLINARY SCIENCES)
55. Hsieh MH, Wang S. C., Hsieh MY, Huang CF, Yeh ML, Yang JF, Chang K, Lin WR, Lin CY, Chen TC, Huang JF, Dai CY, Tsai JJ, Chuang WL, Yu ML. Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan. Kaohsiung J Med Sci. 2016 Oct;32(10):526-530. (SCI, IF:1.150; 103/128 80.5% in MEDICINE, RESEARCH & EXPERIMENTAL)
56. Lu M.Y., Huang C.I., Dai C.Y., Wang S. C., Hsieh M.Y, Hsieh M.H., Liang P.C., Lin Y.H., Hou N.J., Yeh M.L., Huang C.F., Lin Z.Y., Chen S.C., Huang J.F., Chuang W.L., Yu M.L., Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C. Sci Rep. 2016 Mar 11;6:22995. (SCI, IF:4.259; 10/64 15.6% in MULTIDISCIPLINARY SCIENCES)
57. Hsieh M.H., Hsieh M.Y., Huang C.F., Yeh M.L., Wang S. C., Yang J.F., Chang K., Lin W.R., Lin C.Y., Chen T.C., Huang J.F., Dai C.Y., Tsai J.J., Chuang W.L., Yu M.L., Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan. Kaohsiung J Med Sci. 2016 Feb;32(2):96-102. (SCI, IF:1.150; 103/128 80.5% in MEDICINE, RESEARCH & EXPERIMENTAL)
58. Lee K.J., Saha J., Sun J., Fattah K.R., Wang S. C., Jakob B., Chi L., Wang S.Y., Taucher-Scholz G., Davis A.J., Chen D.J., Phosphorylation of Ku dictates DNA double-strand break (DSB) repair pathway choice in S phase. Nucleic Acids Res. 2016 Feb 29;44(4):1732-45. (SCI, IF:10.162; 14/286 4.9% in BIOCHEMISTRY & MOLECULAR BIOLOGY)
59. Yu C.F., Lin C.M., Wang S. C., Chen F.H., Hong J.H., Tsai C.S., Yang Y.C., Chiang C.S., Effects of pre-irradiation and SDF-1 suppression on the progression of murine astrocytoma cells grown in different stromal beds. International Journal of Radiation Biology. 2014 Dec;90(12):1162-8. (SCI, IF:1.992; 3/33 9.1% in NUCLEAR SCIENCE & TECHNOLOGY)
60. Wang S. C.#, Yu C.F., Hong J.H., Tsai C.S., Chiang C.S., Radiation therapy-induced tumor invasiveness is associated with SDF-1-regulated macrophage mobilization and vasculogenesis. PLoS ONE. 2013 Aug 5;8(8):e69182 (SCI, IF:2.806; 15/64 23.4% in MULTIDISCIPLINARY SCIENCES) 本人為第一作者.
61. Wang S. C.#, Hong J.H., Hsueh C., Chiang C.S., Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Laboratory Investigation. Jan;92(1):151-62. (SCI, IF:4.857; 16/128 12.5% in PATHOLOGY) 本人為第一作者.
62. Chiang C.S., Fu S.Y., Wang S. C., Yu C.F., Chen F.H., Lin C.M., Hong J.H., Irradiation promotes an m2 macrophage phenotype in tumor hypoxia. Frontiers in Oncology. 2012 Aug;2:89. (IF:4.66)
63. Li C.Y., Chiang C.S., Cheng W.C., Wang S. C., Chang H.Z., Chen C.R., Shu W.Y., Tsai M.L., Hseu R.S., Chang C.W., Huang C.Y., Fang S.H., Hsu I.C., Gene expression profiling of dendritic cells in different physiological stages under Cordyceps sinensis treatment. PLoS ONE. 2012 Jul;7(7):e40824. (SCI, IF:2.806; 15/64 23.4% in MULTIDISCIPLINARY SCIENCES)
64. Huang F.Y., Lee T.W., Kao C.H., Chang C.H., Zhang X., Lee W.Y., Chen W.J., Wang S. C., Lo J.M., Imaging, autoradiography, and biodistribution of (188)Re-labeled PEGylated nanoliposome in orthotopic glioma bearing rat model. Cancer Biotherapy & Radiopharmaceuticals. 2011 Dec;26(6):717-25. (SCI, IF:1.689; 75/126 59.5% in RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING)
65. Wang S. C.#, Wu C.C., Wei Y.Y., Hong J.H., Chiang C.S. Inactivation of ataxia telangiectasia mutated gene can increase intracellular reactive oxygen species levels and alter radiation-induced cell death pathways in human glioma cells. International Journal of Radiation Biology. 2011 Apr;87(4):432-42. (SCI, IF:1.992; 3/33 9.1% in NUCLEAR SCIENCE & TECHNOLOGY) 本人為第一作者.
66. Li C.Y., Chao L. K., Wang S. C., Chang H. Z., Tsai M. L., Fang S. H., Liao P.C., Ho C.L., Chen S.T., Cheng W.C., Chiang C.S., Kuo Y.H., Hua K.F., Hsu I.C., Honokiol inhibits LPS-induced maturation and inflammatory response of human monocyte-derived dendritic cells. Journal of Cellular Physiology. 2011 Sep;226(9):2338-49. (SCI, IF:4.080; 16/84 19.0% in PHYSIOLOGY.)
67. Luo W.Y., Shih Y.S., Lo W.H., Chen H.R., Wang S. C., Wang C.H., Chien C.H., Chiang C.S., Chuang Y.J., Hu Y.C., Baculovirus vectors for antiangiogenesis-based cancer gene therapy. Cancer Gene Therapy. 2011 Sep;18(9):637-45. (SCI, IF:3.652; 38/158 24.1% in BIOTECHNOLOGY & APPLIED MICROBIOLOGY)
68. Luo W.Y., Shih Y.S., Hung C.L., Lo K.W., Chiang C.S., Lo W.H., Huang S.F., Wang S. C., Yu C.F., Chien C.H., Hu Y.C., Development of the hybrid Sleeping Beauty-baculovirus vector for sustained gene expression and cancer therapy. Gene Therapy. 2012 Aug;19(8):844-51. (SCI, IF:3.110; 49/158 31.0% in BIOTECHNOLOGY & APPLIED MICROBIOLOGY)
69. Méndez, O., Zavadil, J., Esencay, M., Lukyanov, Y., Santovasi, D., Wang, S. C., Newcomb, E. W., Zagzag, D., Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Molecular Cancer. 2010, 1(9):133. (SCI, IF:6.204; 36/286 12.6% in BIOCHEMISTRY & MOLECULAR BIOLOGY)
70. Newcomb, E. W., Lukyanov, Y., Kawashima, N., Alonso-Basanta, M., Wang, S. C., Liu, M., Jure-Kunkel, M., Zagzag, D., Demaria, S. and Formenti S. C., Radiotherapy Enhances Antitumor Effect of Anti-CD137 Therapy in a Mouse Model for Glioma. Radiation Research. 2010, 173(4):426-432. (SCI, IF:2.539; 24/84 28.6% in BIOLOGY.)
71. Liu, W.C., Wang, S.C., Tsai, M.L., Chen, M.C., Wang, Y.C., Hong, J.H., McBride, W.H., Chiang, C.S., Protection against radiation-induced bone marrow and intestinal injuries by Cordyceps sinensis – a Chinese herbal medicine. Radiation Research. 2006, 166(6):900-907. (SCI, IF:2.539; 24/84 28.6% in BIOLOGY.)
72. Wang S.C.#, Chung J.G., Chen C.H., Chen S.C., 2- and 4-Aminobiphenyls induce oxidative DNA damage in human hepatoma (Hep G2) cells via different mechanisms. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 2006, 29;593(1-2):9-21. (SCI, IF:2.581; 58/161 36% in BIOTECHNOLOGY & APPLIED MICROBIOLOGY) 本人為第一作者.
73. Wang S. C.#, Chen C. S., Chen S. C, Flow cytometric measurement of reactive oxygen species production from Hep G2 cell treated with Benzidine and its analogs. Bulletin of Association of Laboratory Medicine. R.O.C. 2003, 18(4): 110-115. 本人為第一作者.